Cargando…
Vaccine development in the SARS-CoV-2 pandemic: a balancing act on accuracy and speed
Autores principales: | Linares-Fernández, Sergio, Raguindin, Peter Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550229/ https://www.ncbi.nlm.nih.gov/pubmed/33047152 http://dx.doi.org/10.1007/s00038-020-01511-2 |
Ejemplares similares
-
SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021) -
The balancing act of disclosing outbreaks of SARS-CoV-2 in workplaces
por: Tran, Maxwell, et al.
Publicado: (2021) -
Targeted vaccination and the speed of SARS-CoV-2 adaptation
por: Gandon, Sylvain, et al.
Publicado: (2022) -
Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies
por: Fajardo, Álvaro, et al.
Publicado: (2022) -
SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes
por: Brewer, R. Camille, et al.
Publicado: (2022)